SloveniaSlovenia

Generics producer to cut jobs, again

17.03.2006

Ljubljana - Lek, the wholly-owned Slovenian subsidiary of Sandoz, Novartis' generics business, will once again cut up to 50 jobs through the course of the year. The redundancies are expected to hit all departments except R&D and biopharmaceuticals, where new jobs may be created, according to the company.
This will be the second wave of redundancies since Lek already reduced its staff by 194 to 2,843 last year. In 2005, the company's sales remained flat at $656.5 million (Euro547 million) and accounting for 14% of Sandoz's sales with prescription medicines contributing to 80% of Lek's total revenue. Exports to central and eastern Europe accounted for 53% of its sales, followed by western Europe, the US and the rest of the world with 36%. The greatest sales growth, more than 40%, was realized in Russia.

SloveniaSlovenia

12.08.2005

Zagreb - Croatia's Government passed a new law on genetically modified organisms (GMO), which replaces the “biotechnology-regulating provisions” of the Law on the Protection of Nature that up to now regulated the importation,...

SloveniaSlovenia

10.07.2005

Ljubljana - Slovenian pharma company Pharmaswiss and Swiss pharma group Helsinn Healthcare SA have signed a licensing agreement granting Pharma-swiss the exclusive license and distribution rights for ALOXI®, a strong and...

SloveniaSlovenia

10.07.2005

Brac - The “Fall 2005 Course on Bioprocess Engineering”, organized by the EFB's Working Group on Bioreactor Performance in collaboration with the European Section on Biochemical Engineering Science, will be held from September...

SloveniaSlovenia

05.02.2005

Zagreb - The 4th International Conference on “Biotechnology and Immunomodulatory Drugs” will open its gates from February 20-23, 2005, in Zagreb, Croatia. Organized amongst others by the Croatian Society of Biotechnology and...

SloveniaSlovenia

09.10.2004

Ljubljana - Slovenia's supreme court has rejected an appeal by US-drug group Merck & Co. Inc. in August, ending a 10-year patent dispute with local drug maker Krka d.d. over one of its best-selling drug. The court rejected a...

SloveniaSlovenia

06.08.2004

Opatija - Nutrition-related biotechnology has been subject to many controverse public debates lately. The organizers of the “2nd Central European Meeting - 5th Croatian Congress of Food Technologists, Biotechnologists und...

SloveniaSlovenia

09.04.2004

Ljubljana - BIA Separations, specialized in the short monolithic column technology, will hold the “First Summer School on Monoliths for Biochro-matography, Bioconversion, and So-lid Phase Synthesis” in Potoroz, Slo-venia, from...

SloveniaSlovenia

05.03.2004

Menges - Lek Pharmaceuticals inaugurated a new manufacturing plant (PORT1) for the production of biopharmaceuticals - such as human proteins for therapeutic applications - near the Slovenian capital Lubljana in Menges in early...

SloveniaSlovenia

05.02.2004

Ljubljana - Slovenian pharmaceutical company Lek d.d. successfully defended in late December its patent EP 1 095 037, which covers Lek's synthesis of Ome-prazole before the Board of Appeal of the European Patent Office....

SloveniaSlovenia

23.11.2003

Ljubljana - Scientists at the Department of Biochemistry and Molecular Biology, Jozef Stefan Institute, Ljubljana, have identified an intracellular membrane receptor for a snake venom secretory phospholipase A (sPLA). The...

Displaying results 11 to 20 out of 22

< Previous 11-20 Next >

© 2007-2014 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-slovenia/browse/1/article/generics-producer-to-cut-jobs-again.html

Product of the week

Products

Events

All Events

Current issue

All issues